You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

topoisomerase-I inhibiting camptothecin

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HRD Cancer, SCLC, Advanced Solid Tumors Trial run by the NCI (Berzosertib, Sacituzumab Govitecan)

Recruiting
  • HRD Cancer
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Metastatic Lung Small Cell Carcinoma, Metastatic Malignant Solid Tumor, Metastatic Neuroendocrine Carcinoma Trial in United

Recruiting
  • Metastatic Lung Small Cell Carcinoma
  • +16 more
  • Phoenix, Arizona
  • +10 more
Mar 25, 2022

Metastatic Colorectal Carcinoma, Metastatic Lung Carcinoma, Metastatic Lung Small Cell Carcinoma Trial in United States

Recruiting
  • Metastatic Colorectal Carcinoma
  • +29 more
  • Los Angeles, California
  • +22 more
Jun 28, 2022

Colorectal Cancer Trial in Beijing (68Ga-EB-ss-CPT, 64Cu-EB-ss-CPT)

Recruiting
  • Colorectal Cancer
  • Beijing, Beijing, China
    Chinese Academy of Medical Science & Peking Union Medical Colleg
Jun 6, 2023

Carcinoma, Small Cell Trial in Hwasun (Belotecan, Etoposide, Cisplatin)

Completed
  • Carcinoma, Small Cell
  • Hwasun, Korea, Republic of
    Chonnam National University Hwasun Hospital
Aug 2, 2021

Urothelial Carcinoma, Urothelial Cancer, Lung Tumors Trial run by the NCI (EP0057, olaparib)

Recruiting
  • Urothelial Carcinoma
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

Advanced Cancer Trial in Guangzhou (TQB2102 injection)

Not yet recruiting
  • Advanced Cancer
  • TQB2102 injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Feb 23, 2023

Tumors, Lymphoma Trial run by the National Cancer Institute (NCI) (LMP400, LMP776)

Completed
  • Neoplasms
  • Lymphoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 7, 2022

Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Beijing (HS-20089)

Not yet recruiting
  • Ovarian Cancer
  • +3 more
  • Beijing, Beijing, China
    Lingying Wu
Aug 22, 2023

Metastatic Castration Resistant Prostate Cancer, Prostate Tumors Trial run by the NCI (enzalutamide, CRLX101)

Terminated
Has Results
  • Metastatic Castration Resistant Prostate Cancer
  • Prostate Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jun 16, 2022

Breast Cancer Trial in China (TQB2102 for injection)

Not yet recruiting
  • Breast Cancer
  • TQB2102 for injection
  • Hefei, Anhui, China
  • +20 more
Nov 1, 2023

Gastro-Oesophageal Cancer Trial in Worldwide (Regorafenib, Nivolumab, Docetaxel)

Recruiting
  • Gastro-Oesophageal Cancer
  • Scottsdale, Arizona
  • +74 more
Jan 11, 2022

Adenocarcinoma, Gastric, Tumor, Breast Trial in Taipei (DS-8201a)

Completed
Has Results
  • Adenocarcinoma, Gastric
  • Neoplasm, Breast
  • Taipei, Taiwan
  • +1 more
Nov 2, 2022

HER2-Positive Breast Carcinoma, Metastatic Malignant Solid Tumor, Refractory Malignant Solid Tumor Trial in United States

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +4 more
  • Biopsy
  • +3 more
  • Bethesda, Maryland
  • +4 more
Jan 21, 2023

Endometrial Serous Adenocarcinoma, Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in United States

Recruiting
  • Endometrial Serous Adenocarcinoma
  • +2 more
  • Biopsy
  • +3 more
  • Phoenix, Arizona
  • +3 more
Feb 2, 2023

Advanced Uveal Melanoma, Metastatic Uveal Melanoma, Unresectable Uveal Melanoma Trial (BRD4 Inhibitor PLX2853, Trametinib,

Not yet recruiting
  • Advanced Uveal Melanoma
  • +2 more
  • BRD4 Inhibitor PLX2853
  • +4 more
  • (no location specified)
Jan 9, 2023

Advanced Malignant Tumor Trial in Guangzhou, Zhengzhou, Nanjing (TQB3915 tablets)

Recruiting
  • Advanced Malignant Tumor
  • TQB3915 tablets
  • Guangzhou, Guangdong, China
  • +2 more
Jun 9, 2022

Peritoneal Carcinomatosis, Peritoneal Metastases, Colorectal Cancer Trial in Ghent (PIPAC with Nal-IRI)

Recruiting
  • Peritoneal Carcinomatosis
  • +7 more
  • PIPAC with Nal-IRI
  • Ghent, East-Flanders, Belgium
    UZ Ghent
Dec 28, 2022

Melanoma, Non-small Sell Lung Cancer (NSCLC), Triple Negative Breast Cancer Trial in Worldwide (PDR001)

Completed
Has Results
  • Melanoma
  • +4 more
  • PDR001
  • Baltimore, Maryland
  • +40 more
Aug 2, 2022

Kidney Transplant; Complications Trial in Odense (Standardized sodium diet, Tbl amiloride)

Completed
  • Kidney Transplant; Complications
  • Standardized sodium diet
  • Tbl amiloride
  • Odense, Denmark
    Odense University Hospital
Dec 23, 2022

Melasma Trial in Bandung (10% Curcuma xanthorriza Roxb., 2% Kojic Acid)

Recruiting
  • Melasma
  • 10% Curcuma xanthorriza Roxb.
  • 2% Kojic Acid
  • Bandung, West Java, Indonesia
    Hasan Sadikin General Hospital
Nov 22, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Chongqing (Esketamine, Sufentanil)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jan 2, 2023

Peripheral Arterial Disease Trial in Germany (Transluminal Angioplasty with Paclitaxel-coated Luminor® Balloon Catheter in the

Active, not recruiting
  • Peripheral Arterial Disease
  • Transluminal Angioplasty with Paclitaxel-coated Luminor® Balloon Catheter in the Superficial Femoral and Popliteal Arteries
  • Transluminal Angioplasty with and non-coated (CE-marked) plain old angioplasty balloon (POBA) catheter
  • Karlsbad-Langensteinbach, Baden-Wuertemberg, Germany
  • +10 more
Oct 19, 2022

Dietary Supplement With and WithoutProbiotic and/or Antibiotic

Completed
  • Healthy Adults
  • Dietary supplement, probiotic, antibiotic conditioning -all groups
  • Cypress, California
    Altasciences
Aug 13, 2022

Psoriasis, Psoriasis Vulgaris Trial in Gent, Nijmegen (Secukinumab, Ixekizumab, Brodalumab)

Recruiting
  • Psoriasis
  • Psoriasis Vulgaris
  • Brussels, Belgium
  • +18 more
Dec 5, 2022